NEOGENNSENeogen Chemicals LimitedHighNegative
Announced Wed, 8 Apr · 18:45 IST

Dr. Harin Haridas Kanani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

NEOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹1331.70
prior close
₹1328.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.2-0.3-2.0+2.4+3.6+8.3+13.8+13.6+13.6+25.7+31.2+45.7+52.1
Up moveDown movePending
AI summary

Dr. Harin Haridas Kanani, a promoter of Neogen Chemicals Limited, has disclosed the creation of a pledge/encumbrance on 13,19,083 equity shares held by him on March 30, 2026. This disclosure is filed under Regulation 31(4) of SEBI SAST Regulations, 2011, which requires promoters to disclose any pledge or encumbrance created on their shares. The filing also confirms that no other promoter or person acting in concert created, invoked, or released any encumbrance on the company's shares during the financial year ended March 31, 2026.

Likely market impact

Pledge creation by a promoter can signal potential risk of share dilution if the pledged shares are invoked, which could impact stock sentiment. However, this is a routine regulatory disclosure and does not by itself indicate any negative development.